Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Exploring how catastrophizing affects itch perception in healthy individuals

Official title: Investigation of the Neurophysiological and Psychological Aspects of Itch

Run by Aalborg University · NCT06340438 · Data updated 2026-11-12

This study is testing how different ways of thinking about pain and discomfort, like feeling helpless or worrying too much, affect how healthy people experience itchiness.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment46 (estimated)
SponsorAalborg University
Academic / other
Locations1 site (Aalborg, Denmark)
StatusRecruiting
StartedApril 27, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedNovember 6, 2026
Trial IDNCT06340438 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy men and women aged 18-60 who can speak and understand English.

Probably not a fit

Patients with a history of neurological, immunological, or mental health disorders, as well as those with skin diseases, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the relationship between different dimensions of catastrophizing, such as rumination and helplessness, and their impact on itch and pain intensity in healthy individuals. The study aims to understand how cognitive and emotional factors, along with personality traits like anxiety sensitivity, influence the perception of itch. By using interventions like histamine and cowhage, researchers will assess how these factors modulate itch responses in a controlled experimental setting. The findings could provide insights into the psychological aspects of chronic itch and pain.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of chronic itch, potentially enhancing quality of life for affected patients.

How similar studies have gone: While the relationship between catastrophizing and pain is well-documented, this specific investigation into itch perception is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy men and women
* 18-60 years
* Speak and understand English

Exclusion Criteria:

* Pregnancy or lactation
* Drug addiction defined as any use of cannabis, opioids, or other addictive drugs
* Previous or current history of neurological (e.g. neuropathy), immunological (e.g. asthma, immune deficiencies, arthritis), musculoskeletal (e.g. muscular pain in the upper extremities,), cardiac disorder, or mental illnesses that may affect the results
* Lack of ability to cooperate
* Current use of medications that may affect the trial such as antihistamines, antipsychotics, and pain killers, as well as systemic or topical steroids
* Skin diseases (e.g. atopic dermatitis, pruritus nodularis, eczema, psoriasis)
* Moles, scars, or tattoos in the area to be treated or tested.
* Consumption of alcohol or painkillers 24 hours before the study days and between these
* Acute or chronic pain
* Participation in other trials within one week of study entry (four weeks in the case of pharmaceutical trials)

Where it's running

  • Aalborg University
    Aalborg, Denmark, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.